SCHEMBL28098263

SCHEMBL28098263

O=COCc1ccc2ncc(Cl)cc2c1

nearest known ligand 0.39

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
KLKB1 P03952 19/20 0.39
MAP4K1 Q92918 11/20 0.39
TEC P42680 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28309061 0.82 CYP1A2 (0.44) KLKB1MAP4K1
SCHEMBL27834462 0.79 SMN1; SMN2 (0.40) TEC
SCHEMBL28085979 0.78 EGFR (0.46)
SCHEMBL553917 0.77 MET (0.41) KLKB1MAP4K1TEC
SCHEMBL17442812 0.76 KLKB1 (0.42) KLKB1MAP4K1
SCHEMBL7274371 0.76 NPC1 (0.47)
SCHEMBL28328429 0.76 TEC (0.46) TEC
SCHEMBL22276493 0.74 CYP1A2 (0.41) KLKB1MAP4K1
SCHEMBL554212 0.74 KLKB1 (0.44) KLKB1MAP4K1
Hydrochloric Acid SCHEMBL28309817 0.74 KLKB1 (0.41) KLKB1MAP4K1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110022875-A Therapeutic inhibiting compound 莱福斯希医药公司 2019-07-16 CN disclosed
CN-105968115-A Quinoline compounds and preparation method thereof, and intermediate, pharmaceutical composition and application of quinoline compounds 上海医药集团股份有限公司 2016-09-28 CN disclosed